Methods and systems of detecting plasma protein biomarkers for diagnosing acute exacerbation of COPD
US10942188B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2016 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Feb 20, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/122
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described are compositions and methods for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Multiple reaction monitoring mass spectrometry (MRM-MS) was used to quantify the amount of protein biomarkers in plasma samples from human subjects. The amount of the biomarkers in the sample can distinguish AECOPD from a stable or convalescent state of COPD, or from a subject without COPD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.